Insmed
INSM
#1051
Rank
โ‚ฌ20.25 B
Marketcap
93,44ย โ‚ฌ
Share price
-1.82%
Change (1 day)
6.72%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -โ‚ฌ0.94 Billion

According to Insmed's latest financial reports the company's current earnings are โ‚ฌ0.81 Billion. In 2025 the company made an earning of -โ‚ฌ1.05 Billion a decrease over its 2024 earnings that were of -โ‚ฌ0.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.94 Billion-10.25%
2025 -โ‚ฌ1.05 Billion43.91%
2024 -โ‚ฌ0.73 Billion23.71%
2023 -โ‚ฌ0.59 Billion45.77%
2022 -โ‚ฌ0.41 Billion15.83%
2021 -โ‚ฌ0.35 Billion50.19%
2020 -โ‚ฌ0.24 Billion16.4%
2019 -โ‚ฌ0.2 Billion-23.9%
2018 -โ‚ฌ0.27 Billion59.35%
2017 -โ‚ฌ0.17 Billion8.52%
2016 -โ‚ฌ0.16 Billion47.25%
2015 -โ‚ฌ0.11 Billion34.53%
2014 -โ‚ฌ76.38 Million58.83%
2013 -โ‚ฌ48.09 Million35.14%
2012 -โ‚ฌ35.59 Million-31.92%
2011 -โ‚ฌ52.27 Million854.92%
2010 -โ‚ฌ5.48 Million-105.22%
2009 โ‚ฌ0.10 B-905.06%
2008 -โ‚ฌ13.02 Million-27.31%
2007 -โ‚ฌ17.91 Million-62.41%
2006 -โ‚ฌ47.65 Million98.19%
2005 -โ‚ฌ24.04 Million0.03%
2004 -โ‚ฌ24.03 Million159.07%
2003 -โ‚ฌ9.28 Million-69.31%
2002 -โ‚ฌ30.23 Million
2000 -โ‚ฌ27.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚ฌ13.82 B-1,532.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
โ‚ฌ9.39 B-1,073.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ4.43 B-559.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ21.43 M-102.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚ฌ20.37 Million-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-โ‚ฌ20.61 Million-97.87%๐Ÿ‡บ๐Ÿ‡ธ USA